Bayesian Model Projecting Cardiovascular Disease Related Mortality Trends in the United States
In the United States, between 2020 and 2035, the aSMR for IHD is expected to decrease, for CeVD will remain stable, and for HF will increase substantially. These data can inform resource allocation for future public health initiatives.
Authors
- Mark C. Petrie (ORCID: https://orcid.org/0000-0002-6333-9496)
- Salim S. Virani (ORCID: https://orcid.org/0000-0001-9541-6954)
- Sanjay Rajagopalan (ORCID: https://orcid.org/0000-0001-6669-8163)
- Pedro Rafael Vieira de Oliveira Salerno (ORCID: https://orcid.org/0000-0002-5116-5062)
- Sadeer G Al-Kindi (ORCID: https://orcid.org/0000-0002-1122-7695)
- Salil V. Deo (ORCID: https://orcid.org/0000-0002-4729-1461)
- Yakov Elgudin (ORCID: https://orcid.org/0000-0002-5249-1820)
- Khurram Nasir (ORCID: https://orcid.org/0000-0001-5376-2269)
- Naveed A. Sattar (ORCID: https://orcid.org/0000-0002-1604-2593)
- Antoinette Cotton (ORCID: https://orcid.org/0009-0000-8917-9542)
Institutions
- Aga Khan University (PK)
- University Hospitals of Cleveland (US)
- Baylor School (US)
- Methodist Hospital (US)
- Louis Stokes Cleveland VA Medical Center (US)
- University School (US)
- Case Western Reserve University (US)
- University of Glasgow (GB)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1161/jaha.124.035922
- Citations
- 3
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.21
Funders
- Amgen
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Boston Scientific Corporation
- Horizon Therapeutics
- National Institute for Health and Care Research
- Novo Nordisk
- National Institutes of Health